- Home/Capabilities/503b Compounding
At KRS we provide innovative, effective and safe solutions to some of the greatest challenges in today’s medical environment.

Our team of professionals is dedicated to delivering the most effective preparations possible to meet patients’ and health care professionals’ needs
In November of 2013, President Barack Obama signed the Compounding Quality Act which forced the compounding industry to follow certain guidelines to ensure the safety and quality of the products they prepare. Far removed from the days of mortar and pestle compounding, we are now known as a 503b Human Outsourcing Facility.
KRS is an industry leading customized FDA-registered and inspected 503b Human Outsourcing Facility that provides sterile compounding service to patients, surgery centers, ophthalmology clinics, hospitals and universities nationwide.